Justin M. Balko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Justin M. Balko has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- Paula I. Gonzalez-Ericsson
Departments of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center (VUMC), Nashville, Tennessee, USA
221 shared publications - Melinda E. Sanders
Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee
183 shared publications - Vandana G. Abramson
Vanderbilt University, Nashville, TN
132 shared publications - Violeta Sanchez
Department of Medicine, Vanderbilt University, Nashville, USA
125 shared publications - Xiaopeng Sun
Cancer Biology Program, Vanderbilt University, Nashville, Tennessee
125 shared publications - Susan R. Opalenik
Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
114 shared publications
Latest Publications
- Open Access
- 29 September 2026
- Published by Elsevier in Cell Reports Medicine
- Vol. 7 (10)
A multi-omics analysis of advanced triple-negative breast cancer identifies predictors to chemo-immunotherapy and on-treatment dynamics
- 29 September 2026
- Published by Elsevier in Cell Reports Medicine
- Vol. 7 (10)
Open AccessA multi-omics analysis of advanced triple-negative breast cancer identifies predictors to chemo-immunotherapy and on-treatment dynamics
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from In Situ Detection of Individual Classic MHC-I Gene Products in Cancer
Supplementary Figure 2 Representative images showing expected architectural expression
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from In Situ Detection of Individual Classic MHC-I Gene Products in Cancer
Supplementary Figure 2 Representative images showing expected architectural expression
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S6 from In Situ Detection of Individual Classic MHC-I Gene Products in Cancer
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S6 from In Situ Detection of Individual Classic MHC-I Gene Products in Cancer
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from In Situ Detection of Individual Classic MHC-I Gene Products in Cancer
Supplementary Figure 1 Scatter plots showing example of flow cytometry gating strategy:
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from In Situ Detection of Individual Classic MHC-I Gene Products in Cancer
Supplementary Figure 1 Scatter plots showing example of flow cytometry gating strategy:
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from In Situ Detection of Individual Classic MHC-I Gene Products in Cancer
Supplementary Table S5 from In Situ Detection of Individual Classic MHC-I Gene Products in Cancer
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from In Situ Detection of Individual Classic MHC-I Gene Products in Cancer
Supplementary Table S5 from In Situ Detection of Individual Classic MHC-I Gene Products in Cancer
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from In Situ Detection of Individual Classic MHC-I Gene Products in Cancer
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from In Situ Detection of Individual Classic MHC-I Gene Products in Cancer
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from In Situ Detection of Individual Classic MHC-I Gene Products in Cancer
Supplementary Figure 4 HLA-AB loss with unknown HLA-C expression
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from In Situ Detection of Individual Classic MHC-I Gene Products in Cancer
Supplementary Figure 4 HLA-AB loss with unknown HLA-C expression
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from In Situ Detection of Individual Classic MHC-I Gene Products in Cancer
Supplemental Figure 3 Heatmaps showing cell DAB intensity for each allele and antibody.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from In Situ Detection of Individual Classic MHC-I Gene Products in Cancer
Supplemental Figure 3 Heatmaps showing cell DAB intensity for each allele and antibody.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from In Situ Detection of Individual Classic MHC-I Gene Products in Cancer
Supplementary Figure 5 Stromal TILs according to HLA-A, B and C loss or retained (conserved or regional loss) status for patient cohort with TNBC (A), HR + HER2- (B) and HER2+ breast cancer (C).
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from In Situ Detection of Individual Classic MHC-I Gene Products in Cancer
Supplementary Figure 5 Stromal TILs according to HLA-A, B and C loss or retained (conserved or regional loss) status for patient cohort with TNBC (A), HR + HER2- (B) and HER2+ breast cancer (C).
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from In Situ Detection of Individual Classic MHC-I Gene Products in Cancer
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from In Situ Detection of Individual Classic MHC-I Gene Products in Cancer